TWKS - Bragar Eagel & Squire P.C. Is Investigating Thoughtworks Chemours Methanex and Inari Medical and Encourages Investors to Contact the Firm | Benzinga
NEW YORK, March 08, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Thoughtworks Holding, Inc. (NASDAQ:TWKS), The Chemours Company (NYSE:CC), Methanex Corporation (NASDAQ:MEOH), and Inari Medical, Inc. (NASDAQ:NARI). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
Thoughtworks Holding, Inc. (NASDAQ:TWKS)
On February 12, 2024, Thoughtworks disclosed in a filing with the U.S. Securities and Exchange Commission that "[o]n February 6, 2024, the Audit Committee of the Board of Directors (the ‘Audit Committee') of Thoughtworks Holding, Inc. (the "Company"), concluded . . . that the Company's previously issued unaudited condensed consolidated financial statements as of and for the quarterly periods ended June 30, 2023 and September 30, 2023 (collectively, the ‘Non-Reliance Periods') included in the Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission (the ‘SEC') for the Non-Reliance Periods, (1) should no longer be relied upon due to an inaccurate presentation of the change in cash flows ascribed to operating activities in the condensed consolidated statement of cash flows, as further described below, and (2) will require restatement."
Thoughtworks stated that "[a]s previously disclosed . . . in the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 and September 30, 2023, the Company made a payment of contingent consideration related to the acquisition of Connected Lab Inc. of $14.3 million. ...